NCT03770702RecruitingPhase 3
Statins and ARBs on Rheumatoid Activity
Investigational and Comparative Study Between the Anti-inflammatory Effectof Both Angiotensin Reeptor Blockers and Statins on Rheumatoid Arthritis Disease Activity on Egyptian Patients
Source: ClinicalTrials.gov · Last updated 10 Dec 2018 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
Investigational and comparative study between the anti-inflammatory effectof both angiotensin reeptor blockers and statins on rheumatoid arthritis disease activity on Egyptian patients
- Status (registry)
- Recruiting
- Phase (registry)
- Phase 3
- Study type
- Interventional
- Enrollment
- 45 (estimated)
- First submitted
- 7 Dec 2018
- Start date
- 1 Oct 2018
- Primary completion date
- 1 Dec 2025
- Lead sponsor
- Sherief Abd-Elsalam
- Diseases
- Rheumatoid arthritis
- NCT number
- NCT03770702
What you commit to
- Study type: Interventional · Phase 3
- Planned participants: 45
- From 1 Oct 2018 to the primary completion date, 1 Dec 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Hepatic or renal impairment.
Other
- Pregnant or lactating
Who the study is looking for
- Rheumatoid arthritis.
Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Sherief Abd-Elsalam Coordinator of this site? Confirm its status | Tanta | Egypt | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.